Genscript Biotech Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GNNSF research report →
About the company
Genscript Biotech Corporation, an investment holding firm, operates on a global scale as a leading provider of life science research products and services, serving North America, Europe, China, Japan, other Asia Pacific regions, and beyond. The company is structured into four distinct business units. Its Life Science Services and Products division delivers essential research support, encompassing gene synthesis, molecular cloning, oligonucleotide and peptide synthesis, protein engineering, antibody development, and the creation of molecular diagnostic tools and genome editing materials.
- CEO
- Weihui Shao
- IPO
- 2017
- Employees
- 5,568
- HQ
- Nanjing, CN
Price Chart
- Market Cap
- $3.50B
- P/E
- -7.10
- P/S
- 3.95
- P/B
- 0.96
- EV/EBITDA
- 12.21
- Div Yield
- 0.00%
- Gross Margin
- 57.65%
- Op Margin
- 26.60%
- Net Margin
- -55.53%
- ROE
- -12.72%
- ROIC
- 5.54%
- Revenue
- $960.95M · 61.64%
- Net Income
- $-533,618,209 · -118.02%
- EPS
- $-0.25 · -117.86%
- Op Income
- $255.62M
- FCF YoY
- 434.41%
- 52W High
- $2.42
- 52W Low
- $1.30
- 50D MA
- $1.63
- 200D MA
- $1.81
- Beta
- 0.85
- Avg Volume
- 38
Get TickerSpark's AI analysis on GNNSF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our GNNSF coverage
Recent articles, reports, and earnings notes.
No research on GNNSF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate GNNSF report →Similar companies
Peers in the same neighborhood.